Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. I. Preparation and in vitro degradation
- PMID: 20544804
- DOI: 10.1002/jbm.a.32824
Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. I. Preparation and in vitro degradation
Abstract
Bioactive glass scaffolds with a microstructure similar to that of dry human trabecular bone but with three different compositions were evaluated for potential applications in bone repair. The preparation of the scaffolds and the effect of the glass composition on the degradation and conversion of the scaffolds to a hydroxyapatite (HA)-type material in a simulated body fluid (SBF) are reported here (Part I). The in vitro response of osteogenic cells to the scaffolds and the in vivo evaluation of the scaffolds in a rat subcutaneous implantation model are described in Part II. Scaffolds (porosity = 78-82%; pore size = 100-500 microm) were prepared using a polymer foam replication technique. The glasses consisted of a silicate (13-93) composition, a borosilicate composition (designated 13-93B1), and a borate composition (13-93B3), in which one-third or all of the SiO2 content of 13-93 was replaced by B2O3, respectively. The conversion rate of the scaffolds to HA in the SBF increased markedly with the B2O3 content of the glass. Concurrently, the pH of the SBF also increased with the B2O3 content of the scaffolds. The compressive strengths of the as-prepared scaffolds (5-11 MPa) were in the upper range of values reported for trabecular bone, but they decreased markedly with immersion time in the SBF and with increasing B2O3 content of the glass. The results show that scaffolds with a wide range of bioactivity and degradation rate can be achieved by replacing varying amounts of SiO(2) in silicate bioactive glass with B2O3.
Copyright 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2010.
Similar articles
-
Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. II. In vitro and in vivo biological evaluation.J Biomed Mater Res A. 2010 Oct;95(1):172-9. doi: 10.1002/jbm.a.32823. J Biomed Mater Res A. 2010. PMID: 20540099
-
Conversion of borate-based glass scaffold to hydroxyapatite in a dilute phosphate solution.Biomed Mater. 2010 Feb;5(1):15005. doi: 10.1088/1748-6041/5/1/015005. Epub 2010 Jan 7. Biomed Mater. 2010. PMID: 20057014
-
Bone regeneration in rat calvarial defects implanted with fibrous scaffolds composed of a mixture of silicate and borate bioactive glasses.Acta Biomater. 2013 Nov;9(11):9126-36. doi: 10.1016/j.actbio.2013.06.039. Epub 2013 Jul 1. Acta Biomater. 2013. PMID: 23827095
-
Binary CaO-SiO(2) gel-glasses for biomedical applications.Biomed Mater Eng. 2004;14(4):467-86. Biomed Mater Eng. 2004. PMID: 15472395 Review.
-
Three-dimensional glass-derived scaffolds for bone tissue engineering: current trends and forecasts for the future.J Biomed Mater Res A. 2011 Jun 15;97(4):514-35. doi: 10.1002/jbm.a.33072. Epub 2011 Apr 4. J Biomed Mater Res A. 2011. PMID: 21465645 Review.
Cited by
-
The facile synthesis and bioactivity of a 3D nanofibrous bioglass scaffold using an amino-modified bacterial cellulose template.RSC Adv. 2018 Apr 18;8(26):14561-14569. doi: 10.1039/c8ra00352a. eCollection 2018 Apr 17. RSC Adv. 2018. PMID: 35540791 Free PMC article.
-
Manipulating Air-Gap Electrospinning to Create Aligned Polymer Nanofiber-Wrapped Glass Microfibers for Cortical Bone Tissue Engineering.Bioengineering (Basel). 2020 Dec 20;7(4):165. doi: 10.3390/bioengineering7040165. Bioengineering (Basel). 2020. PMID: 33419239 Free PMC article.
-
Conversion of melt-derived microfibrous borate (13-93B3) and silicate (45S5) bioactive glass in a simulated body fluid.J Mater Sci Mater Med. 2013 Mar;24(3):583-95. doi: 10.1007/s10856-012-4831-z. Epub 2012 Dec 12. J Mater Sci Mater Med. 2013. PMID: 23233025
-
Pore graded borosilicate bioactive glass scaffolds: in vitro dissolution and cytocompatibility.J Mater Sci Mater Med. 2024 Mar 20;35(1):17. doi: 10.1007/s10856-024-06791-1. J Mater Sci Mater Med. 2024. PMID: 38507150 Free PMC article.
-
Comparison of Borate Bioactive Glass and Calcium Sulfate as Implants for the Local Delivery of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus-Induced Osteomyelitis in a Rabbit Model.Antimicrob Agents Chemother. 2015 Dec;59(12):7571-80. doi: 10.1128/AAC.00196-15. Epub 2015 Sep 28. Antimicrob Agents Chemother. 2015. PMID: 26416858 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources